24/7 Market News Snapshot 06 June, 2025 – Phathom Pharmaceuticals, Inc. Common Stock (NASDAQ:PHAT)

June 6, 2025

DENVER, Colo., 06 June, 2025 (www.247marketnews.com) – (NASDAQ:PHAT) are discussed in this article.
Phathom Pharmaceuticals, Inc. has recently captured attention in the market with its stock price surging approximately 112.79%, reaching $9.98 after opening at $4.80. This remarkable increase signals strong investor interest, bolstered by an impressive trading volume of 13.60 million shares. Following yesterday’s close of $4.69, this upward movement suggests a growing bullish sentiment, with analysts identifying potential resistance around the $10 mark and support near $5. This dramatic shift in share price may be influenced by the company’s latest developments.

Significantly, Phathom announced the FDA’s approval of its Citizen Petition regarding its flagship product, VOQUEZNA® (vonoprazan). Filed on December 11, 2024, the petition confirms that the FDA intends to amend the Orange Book to grant an extended period of ten years of New Chemical Entity exclusivity for VOQUEZNA®, now confirmed to extend through May 3, 2032. As a first-in-class potassium-competitive acid blocker, VOQUEZNA® is designed for the relief of heartburn associated with Non-Erosive Gastroesophageal Reflux Disease (GERD) in adults, along with supporting the healing of Erosive GERD.

Phathom also offers dosing options via VOQUEZNA® DUAL PAK® and VOQUEZNA® TRIPLE PAK®, addressing H. pylori infection in adults. This extended exclusivity period not only elevates Phathom’s market position but also solidifies its commitment to enhancing treatment options for patients with gastrointestinal diseases.

As Phathom navigates the evolving biopharmaceutical landscape, it remains engaged in its mission to improve access to innovative therapies, anticipating a positive impact on patient outcomes while fostering healthcare collaborations. With these advancements, Phathom Pharmaceuticals is poised for continued growth and success in the biopharmaceutical sector.

Related news for (PHAT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.